Examination of the Order of Incubation for the Recovery of Bacteria and Fungi from Pharmaceutical-grade Cleanrooms
Download in electronic PDF format for $75
Abstract: A study was undertaken to compare microbial recoveries from pharmaceutical grade cleanrooms using two different incubation regimes and a general-purpose agar (Tryptone Soy Agar). One temperature regime (A) incubated plates first at 30°C to 35°C, followed by 20°C to 25°C; the second temperature regime (B) began the incubation with plates at 20°C to 25°C, followed by 30°C to 35°C. The experimental outcomes demonstrated that there was no significant difference with the total microbial count when measured using a t-test (0.05 significance level; 95% confidence interval). However, with the recovery of fungi, the second incubation regime (B), which began with the lower 20°C to 25°C temperature, produced higher incidents and numbers of fungi. While this finding might provide the basis for adopting one incubation regime over another, a review of the types of cleanrooms recovering fungi suggests that fungal incidents are low, and they are more often confined to specific areas. Thus, as an alternative, incubation regimes could be varied to suit different cleanroom environments or a selective mycological agar adopted for specific areas.
Related Keywords:
microbial recovery, pharmaceutical grade cleanroom, incubation regimes, agar media, Tryptone soy agar, formulation, bacterial contamination, fungi, fungal contamination, environmental monitoring, good manufacturing processes, culture conditions
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Examination of the Order of Incubation for the Recovery of Bacteria and Fungi from Pharmaceutical-grade Cleanrooms
Sandle Tim
|
May/Jun 2014
Pg. 242-247
|
Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy: Science and Compliance
Grilli Anthony, Sutton Scott
|
Jan/Feb 2015
Pg. 30-37
|
Sterile Basics of Compounding: Contamination Control Strategies, Part 2
Summers Amy
|
Nov/Dec 2022
Pg. 497-504
|
Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2
Vu Nicole, Lou Jessica R, Kupiec Thomas C
|
Jul/Aug 2014
Pg. 305-310
|
Sterile Basics: How to Know if Your Cleanroom Can Consistently Operate Within a State of Control
Summers Amy, Stephens Pat
|
Jan/Feb 2023
Pg. 39-46
|
Microbial Identification in Pharmaceutical Compounding
Hyde Tiffany, Anstead James, Schade Lisa, Zellner James
|
Jan/Feb 2016
Pg. 13-18
|
Purchasing Chemicals for Pharmaceutical Compounding
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 67-68
|
Expecting the Expected: Planning Considerations for Cleanroom Construction
Roberts Patricia A, Kroon Laura
|
Jul/Aug 2021
Pg. 276-281
|
Quality Control Analytical Methods: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 1
Vu Nicole, Lou Jessica R, Kupiec Thomas
|
May/Jun 2014
Pg. 213-221
|
Technology Spotlight: A USP-Grade Water System
Allen Loyd V Jr
|
Jul/Aug 2003
Pg. 286
|
Cleanroom Cleanliness
Mulder Kyle
|
Jan/Feb 2021
Pg. 6-12
|
Compounding to Prevent and Treat Dysbiosis of the Human Vaginal Microbiome
Riepl Mike
|
Nov/Dec 2018
Pg. 456-465
|
PostScription: Cleanroom Standards
Fitzpatrick Mike, Goldstein Ken
|
Mar/Apr 2004
Pg. 160
|
Maintenance of the Cleanroom
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 313
|
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 491-496
|
Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom
Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
|
Jul/Aug 2015
Pg. 268-278
|
Depyrogenation Options for the Compounding Cleanroom
Weller Tom, Bell Jeff, Dullinger Roger, Allen Vern, Anthenat Bruce
|
Nov/Dec 2014
Pg. 446-454
|
Advanced Compounding; How to Investigate Microbiological Excursions at a Sterile Compounding Facility
Summers Amy
|
Mar/Apr 2023
Pg. 114-121
|
Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective
Timko Robert J, Crooker Philip EM
|
Mar/Apr 2014
Pg. 101-111
|
Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings
Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
|
Mar/Apr 2013
Pg. 168-174
|
Return to Top |